---
layout: post
title: "Proposed Data Collection Submitted for Public Comment and Recommendations"
date: 2026-02-05 19:00:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-17986
original_published: 2022-08-22 00:00:00 +0000
significance: 8.00
---

# Proposed Data Collection Submitted for Public Comment and Recommendations

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** August 22, 2022 00:00 UTC
**Document Number:** 2022-17986

## Summary

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled, Centralized Institutional Review for the CDC Expanded Access Investigational New Drug (EA-IND) for Use of Tecovirimat (TPOXX[supreg]) for Treatment of Human Non-Variola Orthopoxvirus Infections. This proposed project is essential to CDC's Monkeypox emergency response and is designed to assist healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under the EA-IND.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/08/22/2022-17986/proposed-data-collection-submitted-for-public-comment-and-recommendations)
- API: https://www.federalregister.gov/api/v1/documents/2022-17986

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
